Home
About
FAQ
History (4)
Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C.
Iron in nonhemochromatotic liver disorders.
Novel role of nuclear receptor Rev-erba in hepatic stellate cell activation: potential therapeutic target for liver injury.
Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Iron in nonhemochromatotic liver disorders.
Alla V, Bonkovsky HL. Iron in nonhemochromatotic liver disorders. Semin Liver Dis. 2005 Nov; 25(4):461-72.
View in:
PubMed
subject areas
Fatty Liver
Hepatitis C
Humans
Iron
Liver Cirrhosis
Oxidative Stress
Porphyria Cutanea Tarda
Risk Factors
authors with profiles
Herbert L. Bonkovsky MD